97 results
Page 5 of 5
10-KT
78jarzcdf2k
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
yiqrw7 6aq
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
f17g6h7imicupg
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
10-K
ky361p81x
29 Sep 14
Annual report
12:00am
8-K
EX-10.1
57tbgx3t5qj cf1
26 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
zpws0sws5 0bsd8t
20 Mar 14
ContraVir Appoints James Sapirstein as Chief Executive Officer and Board Member
12:00am
10-12G/A
EX-99.1
127g 5crzyebxs2
6 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
gh1r5rx0fyif
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-10.5
gp3sl468
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
hnswakud8xvkpoo3cb
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
udyaivm5s6s041
22 Oct 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
s1uw71kv4vifxv yl1
20 Sep 13
Registration of securities (amended)
12:00am
10-12G
EX-10.2
6qnhgvupk8cn
8 Aug 13
Registration of securities
12:00am
10-12G
EX-99.1
tx0 x7o41
8 Aug 13
Registration of securities
12:00am